id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-D-6784-0014,FDA,FDA-2017-D-6784,Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers,Other,Guidance,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2024-11-07T00:34:15Z,,1,0,0900006484e1b788
FDA-2017-D-6784-0013,FDA,FDA-2017-D-6784,Manufacture of Blood Components Using a Pathogen Reduction Device in Blood Establishments: Questions and Answers; Guidance for Industry; Availability,Notice,Notice of Availability,2021-11-04T04:00:00Z,2021,11,2021-11-04T04:00:00Z,,2021-11-09T17:41:05Z,2021-24073,0,0,0900006484e17ebf
FDA-2017-D-6784-0002,FDA,FDA-2017-D-6784,"Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers
Draft Guidance for Industry",Other,Guidance,2017-12-27T05:00:00Z,2017,12,2017-12-27T05:00:00Z,2018-03-28T03:59:59Z,2024-11-07T01:15:33Z,,1,0,0900006482d77d2d
FDA-2017-D-6784-0001,FDA,FDA-2017-D-6784,Implementation of Pathogen Reduction Technology in the Manufacture of Blood Components in Blood Establishments: Questions and Answers; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2017-12-27T05:00:00Z,2017,12,2017-12-27T05:00:00Z,2018-03-28T03:59:59Z,2018-03-29T01:05:21Z,2017-28043,0,0,0900006482d76311
FDA-2017-D-6784-0003,FDA,FDA-2017-D-6784,01 Reference 1 Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components; Guidance for Industry,Supporting & Related Material,Background Material,2017-12-27T05:00:00Z,2017,12,,,2017-12-27T18:06:42Z,,0,0,0900006482d77d2f
FDA-2017-D-6784-0005,FDA,FDA-2017-D-6784,03 Reference 3 Guidance for Industry Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion,Supporting & Related Material,Background Material,2017-12-27T05:00:00Z,2017,12,,,2017-12-27T18:07:24Z,,0,0,0900006482d77d31
FDA-2017-D-6784-0004,FDA,FDA-2017-D-6784,02 Reference 2 Guidance for Industry and FDA Review Staff Collection of Platelets by Automated Methods,Supporting & Related Material,Background Material,2017-12-27T05:00:00Z,2017,12,,,2017-12-27T18:06:48Z,,0,0,0900006482d77d30